SPEG_DANRE
ID SPEG_DANRE Reviewed; 2995 AA.
AC Q696W0;
DT 16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT 13-SEP-2004, sequence version 1.
DT 03-AUG-2022, entry version 115.
DE RecName: Full=Striated muscle preferentially expressed protein kinase;
DE EC=2.7.11.1;
GN Name=speg; Synonyms=apeg1;
OS Danio rerio (Zebrafish) (Brachydanio rerio).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC Danionidae; Danioninae; Danio.
OX NCBI_TaxID=7955;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX PubMed=15185077; DOI=10.1007/s00427-004-0413-5;
RA Sutter S.B., Raeker M.O., Borisov A.B., Russell M.W.;
RT "Orthologous relationship of obscurin and Unc-89: phylogeny of a novel
RT family of tandem myosin light chain kinases.";
RL Dev. Genes Evol. 214:352-359(2004).
CC -!- CATALYTIC ACTIVITY:
CC Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC -!- CATALYTIC ACTIVITY:
CC Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC EC=2.7.11.1;
CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC -!- TISSUE SPECIFICITY: Preferentially expressed in striated muscle.
CC {ECO:0000269|PubMed:15185077}.
CC -!- PTM: May be autophosphorylated. {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC protein kinase family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AY578914; AAT80902.1; -; mRNA.
DR RefSeq; NP_001007110.1; NM_001007109.1.
DR STRING; 7955.ENSDARP00000032236; -.
DR PaxDb; Q696W0; -.
DR PRIDE; Q696W0; -.
DR GeneID; 570504; -.
DR KEGG; dre:570504; -.
DR CTD; 570504; -.
DR ZFIN; ZDB-GENE-030131-3230; spega.
DR eggNOG; KOG0613; Eukaryota.
DR eggNOG; KOG4475; Eukaryota.
DR InParanoid; Q696W0; -.
DR OrthoDB; 12436at2759; -.
DR PhylomeDB; Q696W0; -.
DR Reactome; R-DRE-445355; Smooth Muscle Contraction.
DR Reactome; R-DRE-5627123; RHO GTPases activate PAKs.
DR PRO; PR:Q696W0; -.
DR Proteomes; UP000000437; Genome assembly.
DR Proteomes; UP000814640; Unplaced.
DR GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR GO; GO:0030018; C:Z disc; NAS:ZFIN.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR GO; GO:0004672; F:protein kinase activity; ISS:ZFIN.
DR GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR GO; GO:0007517; P:muscle organ development; ISS:ZFIN.
DR GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR CDD; cd00063; FN3; 2.
DR Gene3D; 2.60.40.10; -; 9.
DR InterPro; IPR003961; FN3_dom.
DR InterPro; IPR036116; FN3_sf.
DR InterPro; IPR007110; Ig-like_dom.
DR InterPro; IPR036179; Ig-like_dom_sf.
DR InterPro; IPR013783; Ig-like_fold.
DR InterPro; IPR013098; Ig_I-set.
DR InterPro; IPR003599; Ig_sub.
DR InterPro; IPR003598; Ig_sub2.
DR InterPro; IPR011009; Kinase-like_dom_sf.
DR InterPro; IPR000719; Prot_kinase_dom.
DR InterPro; IPR017441; Protein_kinase_ATP_BS.
DR InterPro; IPR015726; Ser/Thr_kin_striated-sp.
DR InterPro; IPR008271; Ser/Thr_kinase_AS.
DR PANTHER; PTHR47633:SF3; PTHR47633:SF3; 3.
DR Pfam; PF00041; fn3; 1.
DR Pfam; PF07679; I-set; 6.
DR Pfam; PF00069; Pkinase; 2.
DR SMART; SM00060; FN3; 2.
DR SMART; SM00409; IG; 7.
DR SMART; SM00408; IGc2; 6.
DR SMART; SM00220; S_TKc; 2.
DR SUPFAM; SSF48726; SSF48726; 7.
DR SUPFAM; SSF49265; SSF49265; 2.
DR SUPFAM; SSF56112; SSF56112; 2.
DR PROSITE; PS50853; FN3; 2.
DR PROSITE; PS50835; IG_LIKE; 6.
DR PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 2.
DR PROSITE; PS00108; PROTEIN_KINASE_ST; 2.
PE 2: Evidence at transcript level;
KW ATP-binding; Disulfide bond; Immunoglobulin domain; Kinase;
KW Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW Serine/threonine-protein kinase; Transferase.
FT CHAIN 1..2995
FT /note="Striated muscle preferentially expressed protein
FT kinase"
FT /id="PRO_0000234340"
FT DOMAIN 27..109
FT /note="Ig-like 1"
FT DOMAIN 613..701
FT /note="Ig-like 2"
FT DOMAIN 714..802
FT /note="Ig-like 3"
FT DOMAIN 840..930
FT /note="Ig-like 4"
FT DOMAIN 937..1035
FT /note="Fibronectin type-III 1"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT DOMAIN 1135..1224
FT /note="Ig-like 5"
FT DOMAIN 1255..1505
FT /note="Protein kinase 1"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT DOMAIN 2323..2413
FT /note="Ig-like 6"
FT DOMAIN 2420..2513
FT /note="Fibronectin type-III 2"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT DOMAIN 2682..2934
FT /note="Protein kinase 2"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT REGION 250..272
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 384..467
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 815..834
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 1559..1582
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 1776..1839
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 2017..2058
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 2163..2189
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 2211..2322
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 2574..2609
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 2648..2676
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 384..409
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 410..430
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 453..467
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 819..834
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 1777..1800
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 1801..1821
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 2017..2033
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 2212..2227
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 2233..2252
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 2257..2288
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 2289..2309
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT ACT_SITE 1372
FT /note="Proton acceptor"
FT /evidence="ECO:0000250"
FT ACT_SITE 2801
FT /note="Proton acceptor"
FT /evidence="ECO:0000250"
FT BINDING 1261..1269
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT BINDING 1283
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT BINDING 2688..2696
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT BINDING 2711
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT DISULFID 50..93
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT DISULFID 639..691
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT DISULFID 861..912
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT DISULFID 2345..2397
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
SQ SEQUENCE 2995 AA; 333684 MW; 7C0F6D54CB6BD34D CRC64;
MRKVTEEKRH SSSMNSSTVE TSFIAAPPVF LRKLKWAAVA AGCDVRLRVC VGGNPRPTLH
WYHNDDPLVI DHEDYDGLWI RDCQQADGGL YTCVAVNHLG EARTSAVLAV LDLEEDSNST
EDESAEPHVS MEMKEQFMPP QGEAINSQPT GRGRAMLSHI PSDGLVVERE MRALGSRAPG
LQEPLSPGRG QLDFKTSEAT PFVQTQPPHK AQASITKSDV DATIDSTATK IKGTKTAMNG
AEVSIKSSKI TGSHQSGGLQ DPSSIQTPKV SQASSKILDR VRAFEEQSHN SNMPKVSSRL
SWGFNRTSSC NSEDETCKAG KFQANTKSDV ALKRSFFKQK ASSLEEQSTY VQKNFQSKLS
EELHRIKKLV GKSNIKKAFS MEQLTQTDKQ SSVSTESVPT QVIQKSEETG KHFTNLKAVP
DAKERWTTLP KEQSSRLPKI NLADKTKQPE NETPPEMNEN QENNSKPTQL LDGQVLNEKV
SFIPGQCSPM LPRTNVSRKW PKSPAQPMVK DGLVQAPQKP PRLLESISTP PTPFKMTIPT
IVVENKPVDE ELDQKEGQIM RQNRDALDDF HTSVEKSIAE APMSELPRKD ALGTAGSELL
QCIIKENTVA RAPAESLLII TRPMQDVKVK AGETALLECF IAGSQAVDVD WLANGKLIQP
ALFDCKMQFD GHRCRLLFKS AHENDSGCYT CKLSTAKEEL ICTANLLVIP SKEPLFTRKL
EVLEAIEGRS AQFDCKVSGC PPPEVTWTHC EKPLVESDNI HILNVNGHHS LLITHVNKES
EGLYTAIAQN VHGKAASSAE LYVQEPRPAI STHMSRLEKM PSIPEEPEVP EGEVERRTMP
DFIKPLSDLE VIEGKEAVLK CRVTGLPYPK ITWYHNGKKI ESTNDRKMTQ YRDVHSLVIQ
SVCHDHSGVY KCVISNKVGK AACYAHLYVA VSLPEPPDGP PVIESVTGRM ILLSWKKPKN
LDPSIDPASL MYVVQQQVLG STQWTTIASS LTDTSYTVTS LSKGVCYSFR VLSTTGKTLS
KPSQPTDLVQ LVDRGEYFRK APVIIDKPDI VYAVENQPVT ITITINHVQA TCTWKRRGVV
LVNKLGALEM TTPDDDQHAL HIAKVKSTDV GQLIFMANNQ YGSDLGTLQL VIAVPPIFET
IMEDLDVCVG ETCHFAVVVD GKPDPDILWY KDGVLLAESS HLTFVYDDRE CSLVVLNAQP
EDVGVYTCTA KNLAGSVSCK AELTVHTAQN VEEEEEQMED EATILRRMRM LTDYYDIHKE
IGRGAFSYVK RVKHKNDQSF AAKFISVRAK KKTCALRELA LLAELDHKSI VRFHDAFEKR
RVVIILTELC HEELLERITK RTTILESEVQ SIIRQLLEGI EYLHQNDIIH LDLKPENILM
ADQKTDQIRI CDFGNALKVK PNEELYCKYG IPEFIAPEIV NQSPISKSTD IWPVGVITYL
CLTGVSPFAG ENDRDTLLNI RNYNVAFEES MFKDLCREAK GFIIKVLVSN KLRPDATECL
LHPWFKSLTK GKSINTTLHK QVLARRKWQC SLIRYGSKMV MRSISELLDD SSSHVSLAVP
RNLKDGSPPP SSSSDSDEDI DELPFIPMPH TMMFSGSRMS LTEIHEVDDK VIRGSNESYK
KNLNQLDDIP ESQIIAGQKN EDYLKNPKRT DNCLQRGSSV EVDQVASKTR RGLMRRGSSA
DSALLLQITP EDNEIKDTTE DSQKHMKKAV SMELPHRSSS PKTAKLSKED YALKLDLMRQ
RLLKGGTVNK NMSGLRGPLL ETLGVDDERR TSSLDRNFRN ARLNASGDSG TFNNDSSEET
YQKPAFRKRS SLRDENSESI SLHRRSGAPL EIPSSSTGDH NVLKIKSTIL DENKANLPPL
FPRDISSKPP TPVLENKQVS KEEANSDVLI MNSSRSAFNL EDTEIKVEEM KEQDSVPENM
NKSTEFPLDI LPHDISSNYC SKLQANGKKA SFLTPLPTPV LKISQPNIQP TAGRPGVFAS
AFSAHQPNLR SDIKNIDSEE IFEARFKKRE SSLAHGLKRL TRTKSEESSP VPQRKSDEVV
YRPGPVGSPL EFGSTGLKEK SKSVQDLREV DKEVGLGLIG RFSMRARKLQ PIDKKEKKEI
SDSVTNKRQL TWATRRSKSL DKKENFETNK ENLEKDTKKI AESPVLAVRR KFESNVSGIF
DRVHSRSKDR KDKETKPHID AEAPNVEKQD MKKINDSPVL ALRKKFETKV SGISYRKQSQ
SEGEGTKFEG QKTPLFSRHH RSQSDGLIHK KMDIPENQLP LQTTTISSKE TLNSSSSAHS
IESSQTPETE IRSRWDRWGL SRGKRDRTPS NSRAPATPKE DFPPVFHIAL KDHVLLEGNP
VTLSCLPAGS PEPKILWLKD KKPLKLCDGM NLEACPDGRQ LLMIMNISKK DAGIYECVAT
NNLASVTTSC ILTLACIPNC PGTPEIRQIY NNTVLVQWKP SDTKVPCTYT IEKKFDGDDK
WLTEATGVTD CFFNSSELPS GSTIRFRVAC VNKAGQSPYS NESDGVSIDT KVTPQHQPAK
MKTHSPASFP AMTAAVATSA FSLSLPSVFS QSISPTPAQS ADVSNTFLEV QSSPKMSTPL
DLPKPASSVN TMPPITQTQT VSPRSYTAPP SIGRSISPVP TYVPATCSLA PTPVSPSVIV
VSSISPIGEG ASSPTPETPT GQAVSSTKSE TTLRQGVPQK PYSFLDEKAR GRFGVIRDCR
ENATGKMFIA KIIPYDQQTK QTIIKEYEIL KSLRCERIMA LHEAYITPRY LVLITEYCSG
KEILQNLIDR FCYSEDDVVG FIVQILQGLE YLHNCKILHL DIKPDNIMVT NLNVIKIIDF
GSAQRFNPLS LQQCSRYLGT LEYMAPEMLK GDLVGPPADI WSLGVLSYIM LSGRHPFEDK
DPQLTEAKIH EAKFDSTKLY PKVSQSASTF LKKILNSYPW CRPTIKDCLN HSWLHDSYLK
KLRRQTLTFT TTRLKEFMGE HQRRCAESAT KHKVILRVYQ GGPSSPASPT KYTTQ